Cargando…
Increase in lesion enhancement on gadoxetic acid enhanced MRI is associated with complete response to neoadjuvant chemotherapy in colorectal liver metastases
Autores principales: | Islam, S, Yin, R, Riddell, A, Tam, H, Jhaveri, K, Koh, DM |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4601739/ http://dx.doi.org/10.1186/1470-7330-15-S1-P3 |
Ejemplares similares
-
Delayed tumour enhancement on gadoxetate-enhanced MRI is associated with overall survival in patients with colorectal liver metastases
por: Cheung, Helen M. C., et al.
Publicado: (2018) -
Randomized multicentre trial of gadoxetic acid-enhanced MRI versus conventional MRI or CT in the staging of colorectal cancer liver metastases
por: Zech, C J, et al.
Publicado: (2014) -
Does Hepatic Steatosis Influence the Detection Rate of Metastases in the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI?
por: Steffen, Ingo G., et al.
Publicado: (2020) -
Aberrant expression of OATP1B3 in colorectal cancer liver metastases and its clinical implication on gadoxetic acid-enhanced MRI
por: Park, Seung Hyun, et al.
Publicado: (2017) -
Diagnostic performance of gadoxetic acid–enhanced liver MRI versus multidetector CT in the assessment of colorectal liver metastases compared to hepatic resection
por: Granata, Vincenza, et al.
Publicado: (2019)